Based on different mechanisms of action, ferroptosis inducers can be roughly divided into iron metabolism inducers, system xc–inhibitors, and GPX4 inhibitors, which are mostly used in the treatment of tumours and neurological diseases (Xia et al., 2021). Here, GPX4 is linked to neoplasm.